News

Articles

Biologics and biosimilars in Brazil – the strategic questions

Our partners Anderson Ribeiro, Aline Ferreira and Priscila Kashiwabara and patent specialist Marisa Momoli authored the chapter "Biologics and biosimilars in Brazil – the strategic questions". This article first appeared in IAM Life Sciences: Key issues for senior life sciences executives 2020, a supplement to IAM, published by Law Business Research – IP Division.
 
Click below to access the full chapter.
Back

Last related news

February 14, 2022

Life sciences patent eligibility in Latin America: a guide

Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that Life sciences patent eligibility in Latin America: a guide

Ler notícia

October 22, 2021

Global Patent Litigation 2022 – Brazil

Our partners Claudio Barbosa and Rafael Lacaz Amaral authored a chapter about Brazil, first appeared in Global Patent Litigation Guide: Helping businesses navigate Global Patent Litigation 2022 – Brazil

Ler notícia

August 17, 2021

Privacy in Brazil 2021

The Q&A guide gives a high-level overview of privacy rules and principles, including what national laws regulate the right to respect for Privacy in Brazil 2021

Ler notícia